TORONTO, Dec. 22, 2023 /CNW/ - MediPharm Labs Corp. (TSX:LABS.TO) (OTC-BB:MEDIF) (FSE:MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced an update regarding its Board of Directors and employee stock issuance.
Read more at newswire.caMediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here